Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Kate Middleton Reminds Us About the Role of Privacy in Healing.

2.

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

3.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

4.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

5.

ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot